These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 21399689)

  • 1. Enhanced neutralization potency of botulinum neurotoxin antibodies using a red blood cell-targeting fusion protein.
    Adekar SP; Segan AT; Chen C; Bermudez R; Elias MD; Selling BH; Kapadnis BP; Simpson LL; Simon PM; Dessain SK
    PLoS One; 2011 Mar; 6(3):e17491. PubMed ID: 21399689
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanisms of enhanced neutralization of botulinum neurotoxin by monoclonal antibodies conjugated to antibodies specific for the erythrocyte complement receptor.
    Sharma R; Zhao H; Al-Saleem FH; Ubaid AS; Puligedda RD; Segan AT; Lindorfer MA; Bermudez R; Elias M; Adekar SP; Simpson LL; Taylor RP; Dessain SK
    Mol Immunol; 2014 Feb; 57(2):247-54. PubMed ID: 24184879
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RBC Adherence of Immune Complexes Containing Botulinum Toxin Improves Neutralization and Macrophage Uptake.
    Al-Saleem FH; Sharma R; Puligedda RD; Elias M; Kattala CD; Simon PM; Simpson LL; Dessain SK
    Toxins (Basel); 2017 May; 9(5):. PubMed ID: 28534855
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fully Human Monoclonal Antibodies Effectively Neutralizing Botulinum Neurotoxin Serotype B.
    Matsumura T; Amatsu S; Misaki R; Yutani M; Du A; Kohda T; Fujiyama K; Ikuta K; Fujinaga Y
    Toxins (Basel); 2020 May; 12(5):. PubMed ID: 32392791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of Monoclonal Antibodies in the Sensitive Detection and Neutralization of Botulinum Neurotoxin Serotype B.
    Cheng LW; Henderson TD; Lam TI; Stanker LH
    Toxins (Basel); 2015 Nov; 7(12):5068-78. PubMed ID: 26633496
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neutralizing Concentrations of Anti-Botulinum Toxin Antibodies Positively Correlate with Mouse Neutralization Assay Results in a Guinea Pig Model.
    Tomic MT; Farr-Jones S; Syar ES; Niemuth N; Kobs D; Hackett MJ; Espinoza Y; Martinez Z; Pham K; Snow DM; Marks JD; Cobb RR
    Toxins (Basel); 2021 Sep; 13(9):. PubMed ID: 34564675
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sequence variation within botulinum neurotoxin serotypes impacts antibody binding and neutralization.
    Smith TJ; Lou J; Geren IN; Forsyth CM; Tsai R; Laporte SL; Tepp WH; Bradshaw M; Johnson EA; Smith LA; Marks JD
    Infect Immun; 2005 Sep; 73(9):5450-7. PubMed ID: 16113261
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficient serum clearance of botulinum neurotoxin achieved using a pool of small antitoxin binding agents.
    Sepulveda J; Mukherjee J; Tzipori S; Simpson LL; Shoemaker CB
    Infect Immun; 2010 Feb; 78(2):756-63. PubMed ID: 19917718
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Production and characterization of a neutralizing antibody against botulinum neurotoxin A.
    Xiong X; Lv S; Fu C; Li L; Sun Z; Han X; Zhang W
    J Immunol Methods; 2020 Dec; 487():112871. PubMed ID: 33007319
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of the monoclonal antibody response to botulinum neurotoxin type A in the complexed and uncomplexed forms.
    Zhao H; Nakamura K; Kohda T; Mukamoto M; Kozaki S
    Jpn J Infect Dis; 2012; 65(2):138-45. PubMed ID: 22446121
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Botulinum neurotoxin neutralizing activity of immune globulin (IG) purified from clinical volunteers vaccinated with recombinant botulinum vaccine (rBV A/B).
    Shearer JD; Vassar ML; Swiderski W; Metcalfe K; Niemuth N; Henderson I
    Vaccine; 2010 Oct; 28(45):7313-8. PubMed ID: 20816903
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Single Tri-Epitopic Antibody Virtually Recapitulates the Potency of a Combination of Three Monoclonal Antibodies in Neutralization of Botulinum Neurotoxin Serotype A.
    Lou J; Wen W; Conrad F; Meng Q; Dong J; Sun Z; Garcia-Rodriguez C; Farr-Jones S; Cheng LW; Henderson TD; Brown JL; Smith TJ; Smith LA; Cormier A; Marks JD
    Toxins (Basel); 2018 Feb; 10(2):. PubMed ID: 29462889
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of human-like scFv-Fc antibodies neutralizing Botulinum toxin serotype B.
    Rasetti-Escargueil C; Avril A; Chahboun S; Tierney R; Bak N; Miethe S; Mazuet C; Popoff MR; Thullier P; Hust M; Pelat T; Sesardic D
    MAbs; 2015; 7(6):1161-77. PubMed ID: 26381852
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of a highly neutralizing single monoclonal antibody to botulinum neurotoxin type A.
    Brier S; Rasetti-Escargueil C; Wijkhuisen A; Simon S; Marechal M; Lemichez E; Popoff MR
    FASEB J; 2021 May; 35(5):e21540. PubMed ID: 33817838
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunological Characterization and Neutralizing Ability of Monoclonal Antibodies Directed Against Botulinum Neurotoxin Type H.
    Fan Y; Barash JR; Lou J; Conrad F; Marks JD; Arnon SS
    J Infect Dis; 2016 May; 213(10):1606-14. PubMed ID: 26936913
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fine and domain-level epitope mapping of botulinum neurotoxin type A neutralizing antibodies by yeast surface display.
    Levy R; Forsyth CM; LaPorte SL; Geren IN; Smith LA; Marks JD
    J Mol Biol; 2007 Jan; 365(1):196-210. PubMed ID: 17059824
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Three Monoclonal Antibody Combination Potently Neutralizes Multiple Botulinum Neurotoxin Serotype E Subtypes.
    Garcia-Rodriguez C; Razai A; Geren IN; Lou J; Conrad F; Wen WH; Farr-Jones S; Smith TJ; Brown JL; Skerry JC; Smith LA; Marks JD
    Toxins (Basel); 2018 Mar; 10(3):. PubMed ID: 29494481
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of neutralizing scFv-Fc against botulinum neurotoxin A light chain from a macaque immune library.
    Miethe S; Rasetti-Escargueil C; Liu Y; Chahboun S; Pelat T; Avril A; Frenzel A; Schirrmann T; Thullier P; Sesardic D; Hust M
    MAbs; 2014; 6(2):446-59. PubMed ID: 24492304
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neutralizing antibodies of botulinum neurotoxin serotype A screened from a fully synthetic human antibody phage display library.
    Yu R; Wang S; Yu YZ; Du WS; Yang F; Yu WY; Sun ZW
    J Biomol Screen; 2009 Sep; 14(8):991-8. PubMed ID: 19726786
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The receptor binding domain of botulinum neurotoxin serotype A (BoNT/A) inhibits BoNT/A and BoNT/E intoxications in vivo.
    Ben David A; Diamant E; Barnea A; Rosen O; Torgeman A; Zichel R
    Clin Vaccine Immunol; 2013 Aug; 20(8):1266-73. PubMed ID: 23761665
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.